Pfizer Inc. (PFE) News Headlines

▮ More

Date

Headline

7/23/2019 8:10:34 AM Syapse Enters Into Strategic Collaboration With Pfizer To Advance Cancer Outcomes Research

7/22/2019 12:41:39 AM InvaGen Receives Final Approval For Generic Version Of Pfizer's Pregabalin Capsules

7/10/2019 2:50:33 AM ViiV : 2-drug Regimen Of Dolutegravir Plus Lamivudine Effective To Control HIV-1

7/3/2019 4:33:40 AM ViiV Healthcare Reports Marketing Authorisation Of Dovato In Europe

7/3/2019 4:14:29 AM GSK: ViiV Healthcare Receives EU Marketing Authorisation For Dovato

7/2/2019 8:20:12 AM Calithera Biosciences Begins Phase 1/2 Trial Of Telaglenastat In Combination With Pfizer’s CDK4/6 Inhibitor Palbociclib

7/1/2019 8:18:36 AM Pfizer Reports Positive Findings From Phase 4 Crisaborole Study - Quick Facts

7/1/2019 8:03:11 AM Pfizer Announces Top-line Results From Phase 4 Study CrisADe CARE 1

6/28/2019 10:40:09 AM Pfizer To Present Initial Phase 1b Data On PF-06939926, Investigational Gene Therapy To Potentially Treat DMD

6/28/2019 7:53:51 AM FDA Approves Pfizer's Zirabev To Treat Five Types Of Cancer

6/28/2019 7:34:59 AM Pfizer Receives FDA Approval For Its Oncology Biosimilar, ZIRABEV

6/28/2019 1:30:41 AM Former FDA Commissioner Scott Gottlieb Joins Pfizer Board - Quick Facts

6/27/2019 4:31:39 PM Pfizer Declares Quarterly Dividend Of $0.36/share, Payable Sept. 3/record Aug. 2

6/27/2019 4:31:21 PM Pfizer Elects Scott Gottlieb To Board Of Directors

6/27/2019 4:30:38 PM Pfizer Inc. (PFE) Declares $ 0.36 Dividend for Q3 19, Record Date 8/2/2019

6/17/2019 8:00:04 AM Pfizer Investor Conference Call At 9:00 AM ET

6/17/2019 7:20:21 AM Pfizer To Acquire Array BioPharma In $11.4 Bln Deal - Quick Facts

6/17/2019 6:57:30 AM Pfizer To Acquire Array For $48/Shr For Total Enterprise Value Of $11.4 Bln

6/12/2019 9:20:44 AM Pfizer Says Study Supports Use Of Xeljanz Alone In Rheumatoid Arthritis

6/12/2019 8:07:40 AM Pfizer Announces Positive Results From XELJANZ XR ORAL Shift Study